CVS Health, one of the largest pharmacy chains in the United States, has announced that it will be discontinuing the sale of decongestants that contain the active ingredient phenylephrine. This move is in response to concerns about the safety of phenylephrine. The ingredient is a common ingredient in decongestants and while it can be effective at relieving sinus congestion, it has been linked to a variety of negative side effects including headaches, restlessness, insomnia, hypertension, and even heart palpitations. The decision to stop selling decongestants with phenylephrine is a positive step towards reducing the potential risks from these types of medications. By limiting the number of products that contain the ingredient, CVS is making it easier for customers to make informed decisions about the types of medications they are taking. CVS will be replacing the phenylephrine products with other decongestant options that do not contain the active ingredient. These include products such as nasal sprays, oral decongestants, and even saline rinses. The decision to pull the decongestants with phenylephrine is being met with overall positive reactions and praise from customers and medical professionals alike. Some experts are also hopeful that this decision will lead to other pharmacists considering similar moves. By doing so, a safer and more informed consumer could be a result of this decision. In addition to being safer, the discontinuation of phenylephrine-containing decongestants is also good for the environment. By reducing the number of products that contain phenylephrine, CVS is helping to reduce the environmental impact of producing and disposing of these products. CVS has made a solid decision in its move to no longer sell decongestants that contain phenylephrine and should be commended for its efforts to protect its customers. This move is also important in that it sets a precedent that other pharmacists can follow in order to ensure the safety and well-being of their customers.